Samsung Galaxy smartwatch users in Korea will soon get a groundbreaking heart health feature. The new Left Ventricular Systolic Dysfunction (LVSD) detection tool aims to help identify early signs of heart failure.
Samsung Introduces LVSD Detection on Galaxy Watch
Samsung announced a new heart health feature for its Galaxy smartwatches that could transform early detection of serious heart conditions. The LVSD detection tool builds on the existing electrocardiogram (ECG) function, which already tracks heart rate and blood pressure.
According to Samsung, LVSD causes nearly 50% of all heart failure cases worldwide. Early detection is crucial since heart failure has a five-year survival rate of just 50% after diagnosis.
Certified in Korea, First of Its Kind
The Samsung Galaxy SmartWatch 8 and Galaxy Watch Ultra will be the first models to receive this function in Korea. The tool was recently certified by the country’s Ministry of Food and Drug Safety (MFDS), making it the first smartwatch in the world to gain approval for LVSD detection.
Samsung worked with Medical AI, a Korean medical device company, to create the detection algorithm. It was trained on data from over 120,000 patients across leading hospitals in Korea, ensuring strong clinical reliability.
Potential Impact on Heart Health
Samsung says the feature can help screen asymptomatic individuals before serious symptoms appear. The company suggests this could reduce the risk of death, though no supporting clinical trial data has been released yet.
“This innovation reflects our focus on developing life-changing health solutions through strong partnerships and cutting-edge technology,” Samsung said in a statement.
Expanding Samsung’s Role in Healthcare
Beyond heart health, Samsung is also exploring brain-computer interface (BCI) technology. The company partnered with Hanyang University to develop an ear-based electroencephalogram (EEG) prototype. This wearable can monitor brainwaves outside laboratory settings and has applications in education, marketing, and mental health.
The study was recently featured in the IEEE Sensors Journal, highlighting the global recognition of Samsung’s collaborative research.
What’s Next for Global Users?
Currently, the LVSD tool is only approved in Korea, and Samsung has not confirmed when it will reach markets like North America or Europe. However, experts say the technology aligns with global healthcare priorities such as proactive patient care and reducing hospitalization costs.
Conclusion: Samsung Galaxy Watch Redefines Heart and Brain Health
With the launch of its LVSD detection tool, Samsung has positioned the Galaxy Watch as a leader in wearable health innovation. By combining AI algorithms with real-world medical data, the company is addressing one of the deadliest cardiovascular risks.
Samsung’s dual focus on heart health and brain health technologies underscores its vision of a smarter, healthier future. As more approvals roll out globally, Galaxy smartwatch users could soon benefit from advanced, life-saving tools directly on their wrists.
ALSO READ: Meta Rolls Out WhatsApp Built-In Message Translation for Android and iOS Users
